http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101513702-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2013-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101513702-B1 |
| titleOfInvention | Composition comprising gene downregulating Phc2 expression for suppressing NKT cell activity and Immunosuppressant using the same |
| abstract | The present invention provides a composition for inhibiting the activity of NKT cells (Nature Killer T Cell) comprising a gene inhibiting Phc2 expression and an immunosuppressant containing the same as an active ingredient. According to the present invention, by controlling the expression of the Phc2 protein, the differentiation and activity of the NKT cell, which plays an important role in the in vivo immune system, can be controlled, and the present invention is very useful for the treatment and / or prevention of autoimmune diseases Can be used. |
| priorityDate | 2013-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 369.